HCW Biologics Inc. Current Assets
HCW Biologics Inc. (HCWB) had Current Assets of $1.14 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $1.14M.
- 2026-03-31: Assets, Current $1.72M.
- 2025-12-31: Assets, Current $2.28M.
- 2025-09-30: Assets, Current $1.59M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $1.14M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.72M 10-Q/A · filed 2026-08-14 |
| 2025-12-31 | $2.28M 10-Q/A · filed 2026-08-14 |
| 2025-09-30 | $1.59M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.90M 10-Q · filed 2025-08-18 |
| 2025-03-31 | $1.89M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.70M 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.09M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.39M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.21M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.40M 10-K · filed 2025-03-28 |
| 2023-09-30 | $13.85M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $19.80M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $29.94M 10-Q/A · filed 2023-08-10 |
| 2022-12-31 | $34.07M 10-K/A · filed 2024-05-15 |
| 2022-09-30 | $28.71M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $34.63M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $37.91M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $40.48M 10-K · filed 2023-03-28 |
| 2021-09-30 | $43.56M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.05M 10-Q · filed 2021-08-13 |
| 2020-12-31 | $12.15M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |